Semaglutide vs Tirzepatide: What’s the Difference?

Semaglutide and tirzepatide are two of the most widely discussed prescription medications for weight management. Both are given as once-weekly injections and can help people reduce appetite, eat less, and lose significant amounts of weight. However, they are not the same medication.

Semaglutide primarily works by activating the GLP-1 receptor, while tirzepatide activates both the GIP and GLP-1 receptors.

This difference in how they work has made tirzepatide particularly interesting for weight management. In a large head-to-head clinical trial involving adults with obesity who did not have type 2 diabetes, tirzepatide produced greater average weight loss than semaglutide after 72 weeks. The average weight reduction was approximately 20.2% with tirzepatide compared with 13.7% with semaglutide. But average clinical-trial results do not mean everyone will lose the same amount of weight. Individual results can vary depending on health, treatment response, lifestyle, medication tolerance, and other factors.

Important: Semaglutide and tirzepatide are prescription medications. They should be used under the supervision of a qualified healthcare professional.

Semaglutide vs Tirzepatide at a Glance

Feature	Semaglutide	Tirzepatide
Main action	GLP-1 receptor agonist	GIP and GLP-1 receptor agonist
Common weight-management brand	Wegovy	Zepbound
Administration	Once weekly	Once weekly
Appetite reduction	Yes	Yes
Helps reduce food intake	Yes	Yes
Weight-loss effect	Significant	Significant
Average weight loss in a 72-week head-to-head trial	13.7%	20.2%
Common side effects	Nausea, diarrhea, constipation, vomiting	Nausea, diarrhea, constipation, vomiting
Prescription medication	Yes	Yes

What Is Semaglutide?

Semaglutide is a medication belonging to a group called GLP-1 receptor agonists. GLP-1 is a hormone naturally produced in the body. It plays an important role in appetite regulation, digestion, and blood sugar control. Semaglutide mimics some of the effects of this hormone. For weight management, semaglutide is available under the brand name Wegovy in the United States. It is used together with a reduced-calorie diet and increased physical activity in eligible individuals.

How does semaglutide help with weight loss?

Semaglutide can influence several processes involved in eating and appetite.

It may:

• Reduce hunger
• Increase feelings of fullness
• Reduce food intake
• Slow stomach emptying
• Affect appetite-related signals in the brain

Because people may feel satisfied after eating smaller portions, their overall calorie intake can decrease. Over time, this can contribute to substantial weight loss.

What Is Tirzepatide?

Tirzepatide is different from semaglutide because it acts on two hormone pathways.

It activates:

• GIP receptors
• GLP-1 receptors

For chronic weight management, tirzepatide is marketed as Zepbound in the United States. Tirzepatide is also used under another brand name, Mounjaro, for the treatment of type 2 diabetes.

How does tirzepatide help with weight loss?

Tirzepatide can affect appetite, food intake, digestion, and metabolic regulation.

It may:

• Reduce hunger
• Increase fullness
• Reduce food intake
• Slow stomach emptying
• Activate GLP-1 pathways
• Activate GIP pathways

The combination of GIP and GLP-1 activity is one of the main differences between tirzepatide and semaglutide.

Semaglutide vs Tirzepatide: How Do They Work?

The simplest way to understand the difference is to look at the hormones they target.

Semaglutide

Semaglutide primarily targets GLP-1.

GLP-1 signaling can affect:

• Appetite
• Satiety
• Food intake
• Stomach emptying
• Blood glucose regulation

Tirzepatide

Tirzepatide targets GIP and GLP-1. GIP and GLP-1 are both hormones involved in metabolic processes and appetite regulation. Because tirzepatide targets two pathways, it has a different mechanism from semaglutide. However, the mechanism alone does not determine how much weight an individual person will lose. Clinical studies provide a better way to understand average treatment effects.

Which One Produces More Weight Loss?

One of the biggest questions people have is whether semaglutide or tirzepatide leads to greater weight loss. A 72-week head-to-head clinical trial directly compared the two medications in adults with obesity who did not have type 2 diabetes.

The average percentage of body weight lost was:

Tirzepatide: 20.2%

Semaglutide: 13.7%

The tirzepatide group therefore had a greater average reduction in body weight during the study. The trial also found greater average reductions in waist circumference with tirzepatide. However, these numbers represent average results from a specific clinical trial population. They should not be treated as a prediction of how much weight a particular person will lose.

What Does That Percentage Mean?

Percentages can sometimes be difficult to visualize. Imagine a person weighs 100 kg before treatment.

If they experienced weight loss equivalent to the averages in the trial:

Semaglutide

13.7% of 100 kg = 13.7 kg

Approximate weight afterward: 86.3 kg

Tirzepatide

20.2% of 100 kg = 20.2 kg

Approximate weight afterward: 79.8 kg

Again, this is simply an illustration based on trial averages. Actual weight loss can be higher or lower.

Does Tirzepatide Always Cause More Weight Loss?

Not necessarily. Clinical trials can tell us how treatments perform on average, but individual responses are different. One person may respond very well to semaglutide, while another may experience greater weight loss with tirzepatide.

Factors that can influence results include:

• Starting weight
• Genetics
• Diet
• Physical activity
• Treatment duration
• Dose
• Medication adherence
• Other health conditions
• Individual tolerance

Therefore, a higher average result in a clinical trial does not mean that every person will experience the same difference.

What Are the Common Side Effects?

Both medications can cause gastrointestinal side effects.

Common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Bloating
• Indigestion
• Reduced appetite

These symptoms can be particularly noticeable when treatment is started or when the dose is increased. For many people, gastrointestinal symptoms become less noticeable as the body adjusts to treatment. However, severe or persistent symptoms should be discussed with a healthcare professional.

Why Do Semaglutide and Tirzepatide Cause Nausea?

Both medications affect appetite and the digestive system. They can slow the movement of food through the stomach and increase feelings of fullness. This can be helpful for weight management because people may naturally eat less.

However, the same effects can contribute to:

• Feeling full for longer
• Nausea
• Bloating
• Constipation
• Vomiting

This is one reason these medications are generally started at a lower dose and increased gradually according to the prescribed treatment plan.

Important Safety Considerations

Semaglutide and tirzepatide are not ordinary dietary supplements or simple weight-loss products. They are prescription medications with important safety considerations.

Thyroid-related warning

Both medications carry a warning concerning thyroid C-cell tumors based on findings from animal studies. They should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or by people with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Pancreatitis

Inflammation of the pancreas, known as pancreatitis, has been reported with medications in this class. Severe or persistent abdominal pain should receive prompt medical attention.

Gallbladder problems

Weight loss and these medications can be associated with gallbladder problems, including gallstones.

Dehydration

Severe vomiting or diarrhea can lead to dehydration and may contribute to kidney problems.

Gastrointestinal problems

Because these medications affect the digestive system, some people can experience significant gastrointestinal symptoms. Anyone experiencing severe or persistent symptoms should contact a healthcare professional.

Semaglutide vs Tirzepatide: Which Has More Side Effects?

Both medications can cause gastrointestinal side effects. Nausea, diarrhea, vomiting, and constipation are among the commonly reported problems. Side effects may be more noticeable during the period when the dose is being increased. It is difficult to say that one medication will definitely cause more side effects for every person because individual tolerance varies. Someone who experiences significant side effects with one medication may tolerate another medication differently.

How Long Do You Need to Take These Medications?

Semaglutide and tirzepatide are generally considered long-term weight-management treatments, rather than short-term solutions. Weight management is often an ongoing process. Some people regain part of the weight they lost after stopping treatment. Appetite can return, and maintaining the same calorie intake may become more difficult. This is why stopping or changing treatment should be discussed with a healthcare professional.

Long-term weight management may involve a combination of:

• Nutrition
• Physical activity
• Resistance training
• Sleep
• Behavioral changes
• Medication when appropriate

Can You Lose Weight Without Semaglutide or Tirzepatide?

Yes. Medication is not the only way to lose weight. For many people, changes in diet, physical activity, sleep, and daily habits can produce meaningful improvements in body weight and health.

A sustainable weight-loss plan may include:

Eat enough protein

Protein can help support muscle while losing weight and may improve feelings of fullness.

Good options include:

• Eggs
• Chicken
• Fish
• Greek yogurt
• Paneer
• Lentils
• Beans
• Soy products
• Lean meat

Increase fiber

Vegetables, fruits, whole grains, beans, and lentils can help increase dietary fiber.

Exercise regularly

Combining aerobic activity with resistance training can support overall health and help preserve muscle during weight loss.

Prioritize sleep

Poor sleep can affect appetite, energy levels, and eating behavior.

Create a sustainable calorie deficit

Weight loss generally requires consuming fewer calories than the body uses over time. Medication can support this process for eligible individuals, but it does not replace healthy lifestyle habits.

Who May Be Eligible for Weight-Loss Medication?

Eligibility depends on the specific medication, country, medical history, and prescribing guidelines. In general, prescription weight-management medications may be considered for adults with:

• A BMI of 30 or higher, or
• A BMI of 27 or higher along with a weight-related health condition

Examples of weight-related conditions include:

• Type 2 diabetes
• High blood pressure
• High cholesterol
• Certain other obesity-related health problems

A healthcare professional should determine whether medication is appropriate.

Wegovy vs Zepbound: What’s the Difference?

Wegovy and Zepbound are two brand-name medications used for chronic weight management.

Wegovy contains semaglutide.

Zepbound contains tirzepatide.

Both are administered once weekly.

The major difference is their mechanism:

Wegovy → GLP-1

Zepbound → GIP + GLP-1

They also have different dosing schedules and prescribing information.

Can You Take Semaglutide and Tirzepatide Together?

You should not combine semaglutide and tirzepatide unless specifically instructed by a healthcare professional. Both medications affect overlapping hormone pathways, and combining them could increase the risk of adverse effects. If someone wants to switch from one medication to another, the transition should be planned with their prescribing healthcare professional.

What Happens When You Stop Taking Them?

Stopping treatment can result in some weight regain. This can happen because the appetite-suppressing effects of the medication are no longer present. Weight regain does not necessarily mean that the medication was ineffective. Maintaining significant weight loss can be challenging because the body can respond to weight loss by increasing hunger and reducing energy expenditure. Long-term weight management therefore often requires ongoing lifestyle strategies and, for some people, continued medical treatment.

What About Muscle Loss?

When someone loses a substantial amount of body weight, the weight lost can include both body fat and lean mass. Preserving muscle is therefore an important part of healthy weight management.

Strategies that may help include:

• Eating adequate protein
• Performing resistance training
• Avoiding unnecessarily extreme calorie restriction
• Staying physically active

People taking weight-loss medication can discuss their protein and exercise needs with a healthcare professional or registered dietitian.

Can Healthy People Use These Medications Just to Lose a Few Kilograms?

Semaglutide and tirzepatide are prescription medications intended for specific medical uses. They are not designed simply as cosmetic weight-loss products. Whether medication is appropriate depends on factors such as BMI, health conditions, medical history, current medications, and overall treatment goals. A healthcare professional can determine whether the potential benefits outweigh the risks for an individual.

Semaglutide vs Tirzepatide: Key Differences

Semaglutide

How it works:
Primarily activates the GLP-1 receptor.

Potential benefits:

• Significant weight loss
• Reduced appetite
• Increased fullness
• Once-weekly administration
• Extensive clinical evidence

Important considerations:

• Gastrointestinal side effects are common
• Weight regain can occur after stopping
• It is not appropriate for everyone
• Requires medical supervision

Tirzepatide

How it works:
Activates both GIP and GLP-1 receptors.

Potential benefits:

• Significant weight loss
• Reduced appetite
• Increased fullness
• Once-weekly administration
• Greater average weight loss than semaglutide in a direct 72-week trial

Important considerations:

• Gastrointestinal side effects are common
• Individual results vary
• Weight regain can occur after stopping
• Requires medical supervision

Frequently Asked Questions

1. Is tirzepatide better than semaglutide for weight loss?

A head-to-head 72-week clinical trial found greater average weight loss with tirzepatide than semaglutide in adults with obesity who did not have type 2 diabetes. The average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide. Individual results can differ.

2. How much weight can you lose with semaglutide?

Weight loss varies between individuals. In the 72-week head-to-head trial, participants receiving semaglutide lost an average of 13.7% of their starting body weight.

3. How much weight can you lose with tirzepatide?

In the same trial, participants receiving tirzepatide lost an average of 20.2% of their starting body weight after 72 weeks. These numbers are averages and should not be considered guaranteed results.

4. Is tirzepatide a GLP-1 medication?

Tirzepatide activates both GIP and GLP-1 receptors. It is therefore commonly described as a dual GIP/GLP-1 receptor agonist.

5. Is semaglutide a GLP-1 medication?

Yes. Semaglutide is a GLP-1 receptor agonist.

6. Which one works faster?

The amount and speed of weight loss vary between individuals. Both medications are gradually increased according to their prescribed dosing schedules, so they should not be judged only by early weight changes.

7. Can you switch from semaglutide to tirzepatide?

A healthcare professional may determine that switching is appropriate for some patients. The transition should be medically supervised rather than done independently.

8. Can you take both medications together?

They should not be combined unless specifically directed by a healthcare professional.

9. Do you need to exercise while taking these medications?

Physical activity remains important. Resistance training can also help support muscle preservation during weight loss.

10. Will you regain weight after stopping?

Some people regain weight after discontinuing weight-management medication. Maintaining healthy eating habits and regular physical activity can remain important after treatment.

Final Takeaway

Semaglutide and tirzepatide are both effective prescription medications for weight management, but they work through different hormone pathways. Semaglutide primarily targets GLP-1, while tirzepatide targets both GIP and GLP-1. In a 72-week head-to-head clinical trial, average weight loss was 13.7% with semaglutide and 20.2% with tirzepatide among adults with obesity who did not have type 2 diabetes. However, these figures are averages rather than guarantees. The right treatment depends on an individual’s health, medical history, eligibility, potential side effects, treatment goals, and response to therapy. Neither medication should be started, stopped, combined, or changed without guidance from a qualified healthcare professional.

Medical Sources & References

1. New England Journal of Medicine — Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Read the NEJM clinical trial

2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Prescription Medications to Treat Overweight & Obesity NIDDK: Prescription Medications for Weight Management

3. U.S. Food and Drug Administration — Wegovy Prescribing Information FDA: Wegovy Prescribing Information

4. U.S. Food and Drug Administration — Zepbound Approval FDA: Zepbound Approval Information

5. U.S. Food and Drug Administration — Concerns About Unapproved GLP-1 Drugs FDA: Information on Unapproved GLP-1 Drugs